In severe asthma, miR-221 specifically regulates airway smooth muscle cell (ASMC) hyperproliferation by targeting cyclin-dependent kinase inhibitors p21WAF1 and CDKN1B/p27, though it does not affect corticosteroid insensitivity [72]. This evidence concerns the gene CDKN1B and asthma.